Once-daily darunavir/ritonavir and abacavir/ lamivudine versus tenofovir/emtricitabine for treatment-naïve patients with a baseline viral load of more than 100 000 copies/ml

AIDS

Volumn 27, Issue 5, 2013, Pages 839-842

  Nishijima, Takeshi ^a,b   Komatsu, Hirokazu ^c   Teruya, Katsuji ^a   Tanuma, Junko ^a   Tsukada, Kunihisa ^a   Gatanaga, Hiroyuki ^a,b   Kikuchi, Yoshimi ^b   Oka, Shinichi ^a,b  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c Saku Central Hospital Advanced Care Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR PLUS LAMIVUDINE; DARUNAVIR PLUS RITONAVIR; EFAVIRENZ; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; RITONAVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; DRUG WITHDRAWAL; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; VIREMIA; VIRUS INHIBITION; VIRUS LOAD;

ADENINE; ANTI-HIV AGENTS; DEOXYCYTIDINE; DIDEOXYNUCLEOSIDES; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; LAMIVUDINE; ORGANOPHOSPHONATES; RITONAVIR; SULFONAMIDES; VIRAL LOAD;

EID: 84876389275     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32835cadb7     Document Type: Article

References (1)

1. Maskew M, Westreich D, Firnhaber C, Sanne I. Tenofovir use and pregnancy among women initiating HAART. AIDS 2012; 26:2393-2397.